AHR and asthma: The spleen tyrosine kinase (Syk) inhibitor NVP-QAB-205 significantly reduced AHR in an ovalbumin-exposed and challenged mouse model of asthma and restored the enhanced response to PM2.5/ozone back to normal levels (29).